Document is current
Any future updates will be listed below
-
Authors
Lapidus, Sarah
Liu, Feimei
Casanovas-Massana, Arnau
Dai, Yile
Huck, John D.
Lucas, Carolina
Klein, Jon
Filler, Renata B.
Strine, Madison S.
Sy, Mouhamad
Deme, Awa B.
Badiane, Aida S.
Dieye, Baba
Ndiaye, Ibrahima Mbaye
Diedhiou, Younous
Mbaye, Amadou Moctar
Diagne, Cheikh Tidiane
Vigan-Womas, Inés
Mbengue, Alassane
Sadio, Bacary D.
Diagne, Moussa M.
Moore, Adam J.
Mangou, Khadidiatou
Diallo, Fatoumata
Sene, Seynabou D.
Pouye, Mariama N.
Faye, Rokhaya
Diouf, Babacar
Nery, Nivison Jr
Costa, Federico
Reis, Mitermayer G.
Muenker, M. Catherine
Hodson, Daniel Z.
Mbarga, Yannick
Katz, Ben Z.
Andrews, Jason R.
Campbell, Melissa
Srivathsan, Ariktha
Kamath, Kathy
Baum-Jones, Elisabeth
Faye, Ousmane
Sall, Amadou Alpha
Vélez, Juan Carlos Quintero
Cappello, Michael
Wilson, Michael
Ben-Mamoun, Choukri
Tedder, Richard
McClure, Myra
Cherepanov, Peter
Somé, Fabrice A.
Dabiré, Roch K.
Moukoko, Carole Else Eboumbou
Ouédraogo, Jean Bosco
Boum, Yap II
Shon, John
Ndiaye, Daouda
Wisnewski, Adam
Parikh, Sunil
Iwasaki, Akiko
Wilen, Craig B.
Ko, Albert I.
Ring, Aaron M.
Bei, Amy K.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (CTSA Grant TL1 TR001864)
National Science Foundation (DGE1752134)
Fogarty International Center (D43TW010540, K01 TW010496)
National Institutes of Health (K08 AI128043, R01 AI168238)
Burroughs Wellcome Fund (Career Award for Medical Scientists)
Ludwig Family Foundation
Mathers Charitable Foundation
Fast Grants
Yale School of Public Health, Yale University (Start-up funds)
Institut Pasteur de Paris and Agence Universitaire de la Francophonie (G45267)
- License Information
-
More Information
Article History
Received: 29 July 2022
Accepted: 19 December 2022
First Online: 22 December 2022
Competing interests
: A.M.R. and Y.D. (Yale University) are named inventors on a patent application describing the REAP technology. A.M.R. is the founder of Seranova Bio. C.B.W. (Yale University)has a patent pending entitled “Compounds and Compositions for Treating, Ameliorating, and/or Preventing SARS-CoV-2 Infection and/or Complications Thereof". KK, EBJ, and JS receive salary and hold stock options from Serimmune Inc.
